Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
18 jul 2007 - 08:26
Statutaire naam
Crucell N.V.
Titel
Crucell announces Vaccine and Protein Business Unit Structure and Management Appointments
Bericht
Leiden, The Netherlands, July 18 2007 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced the establishment of two business units for vaccines and proteins. Dedicated business units will enhance the focus on specific opportunities for both product units and will increase transparency to shareholders by separate reporting of financial results. The company plans to report its annual 2007 results along with the new product business units.
Gerelateerde downloads
Datum laatste update: 22 februari 2026